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Abstract 
Reactive oxygen species (ROS) play a critical role in intracellular signaling mechanisms.  These 
small molecules initiate reversible, post-translational modifications of redox-sensitive proteins.  
Pyruvate kinase (PK) is a key glycolytic enzyme whose activity is modulated by ROS; oxidation inhibits 
its catalytic function through a reaction at a critical cysteine near the active site.  PK’s central role in 
moderating glycolytic flux makes it highly regulated through both structural and allosteric effectors.  
This research explores the extent of cysteine modification of PK under various models of intracellular 
conditions.  PK was treated with oxidants and allosteric regulators, and changes in the enzyme’s activity 
and cysteine reactivity were monitored through spectrophotometric and SDS-PAGE assays.  Addition of 
oxidants decreased both PK activity and cysteine accessibility.  Addition of ATP and fructose-1,6-
bisphosphate (FBP) protected cysteines from tagging and oxidation.  Other allosteric effectors like PEP 
had no effect on cysteine accessibility at low concentrations.  Quantifying the reactivity of PK’s 
cysteines allows researchers to further understand the nuanced relationship that exists between 
intracellular redox conditions and protein activity.  This research has been completed in tandem with 
Julia Zuercher.   
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Introduction 
	
Reactive oxygen species (ROS) are produced at low levels during metabolism. These short-lived 
endogenous species contain oxygen and interact with or damage all classes of biochemical 
macromolecules.  Indeed, ROS can be toxic and even promote cell death.  Understanding the role of 
ROS in oxidative stress has been a critical goal of biochemists since Denham Harman advanced the free 
radical theory of aging in the 1950s.  Oxidative stress has been implicated in a number of pathologies 
from diabetes (Paravicini and Touyz, 2006) to cancer (Trachootham et al., 2009) to neurodegenerative 
diseases (Moreira et al., 2005). Recent work on the subject, however, has unveiled a more nuanced 
relationship; while too much ROS damages cellular components, a minimum level of ROS is required 
for intracellular signaling pathways.  This dual nature of ROS reflects the complexity and balance 
inherent in biochemistry. 
Cells have developed myriad methods to regulate intracellular ROS levels.  Maintenance of the 
cell’s redox balance is critical in homeostasis; thiols are often implicated in this equilibrium due to their 
unique chemistry.  Oxidation of cysteine residues in proteins results in varied responses, from activation 
to multimerization.  Low molecular weight thiols are ubiquitous in cellular environments and can form 
mixed disulfide bridges with redox-sensitive proteins to protect against irreversible oxidation. The 
dynamic regulation of protein activity via thiol chemistry is of particular interest to biochemists.        
Glycolysis is a central metabolic pathway, transforming glucose into energy rich molecules like 
pyruvate.  Pyruvate kinase (PK) is the enzyme that catalyzes the final step of glycolysis, the direct 
transfer of a phosphate group from phosophoenolpyruvate (PEP) to adenosine diphosphate (ADP).  PK 
operates at a critical biochemical juncture and thus modulates the relative rates of catabolism versus 
anabolism; its properties and function will be explored further below.    
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ROS  
ROS refers to superoxide anion, hydrogen peroxide, and other radical and non-radical species 
that can be generated from them such as OH• (Berg et al., 2012).   The mitochondria are the key sites for 
ROS generation (Chen et al., 2003).  These products are created by an incomplete reduction of 
molecular oxygen at complex III of the electron transport chain (ETC) (Wellen and Thompson, 2010).  
Instead of four, only one or two electrons are transferred to O2, yielding partially reduced oxygen in the 
form of superoxide anion (O2•-) and peroxide (O22-) respectively.   
Ground-state molecular oxygen is a paramagnetic biradical.  It is unable to oxidize biological 
macromolecules because of spin restriction; its two unpaired electrons have parallel spin. Any other 
reactant must therefore have parallel spin electrons, but in the opposite direction of oxygen’s spin 
(Krumova and Cosa, 2016).  Most organic species are diamagnetic and thus have electron pairs with 
opposite spins.  The diamagnetism precludes orbital overlap and bond formation.  However, certain 
ROS species such as singlet oxygen (1O2) and peroxide (O22- ) are diamagnetic and do not have spin 
restriction, so they are able to rapidly oxidize and damage intracellular species (Krumova and Cosa, 
2016).    
ROS Modulation 
ROS are inevitably produced in aerobic metabolism (Berg et al., 2012).  To combat the 
potentially damaging effects of oxidation, biological systems have developed strategies to reduce these 
species.   For example, upon its generation, superoxide anion is rapidly reduced to H2O2 by superoxide 
dismutases (SODs) (Berg et al., 2012).  Antioxidant enzymes like catalase, glutathione peroxidases 
(Gpx), and peroxiredoxins (Prx) then scavenge H2O2 (Krengel and Törnroth-Horsefield, 2015).  These 
enzymes work to detoxify the intracellular environment, often using glutathione (GSH) as a substrate for 
reduction. Antioxidant enzymes have high rate constants and high abundance in vivo to halt the 
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formation of ever more dangerous ROS (Sena and Chandel, 2012).  For instance, if H2O2 is not promptly 
scavenged, it can react with ferrous or cuprous ions, which are abundant in cells, leading to the 
formation of highly reactive OH• radicals (Hulea, 2016).  A careful balance must be maintained between 
endogenous redox elements.  Cells have numerous enzymatic tools to modulate ROS levels, such as 
abundant SODs and high GSH levels that maintain Gpx and Prx activity.   
Inevitably, cellular defenses against oxidation are diminished in a process referred to as aging.  
According to Harman’s free radical theory, aging is the progressive accumulation of diverse, deleterious 
changes that increase the chance of disease and death with advancing age (Harman, 2006).  ROS are the 
key damaging agents.  Indeed, Ku et al. demonstrated that mammalian life spans are inversely related to 
the rate of mitochondrial superoxide formation (1993).  Recently, the free radical theory of aging has 
come under question.  It is yet unclear whether ROS are the cause or the consequence of age-associated 
diseases. Excessive levels of ROS engender pathologies, but it appears that a low level of ROS is 
necessary for cell function. 
ROS Signaling 
Highly reactive ROS such as ozone or hydroxyl radical oxidize indiscriminately. Therefore, 
these species are not implicated in ROS signaling.  Less reactive ROS like H2O2 oxidize specific 
residues, initiating reversible, post-translational modifications on certain redox-sensitive proteins.  More 
often than not, ROS signaling is propagated by the oxidation of cysteine thiol groups (Sena and Chandel, 
2012).  H2O2 diffuses through membranes and participates in signaling cascades, even in the nanomolar 
range (Glasauer and Chandel, 2013).  
Recent studies have shown that ROS are critical to signal-transduction pathways.  Sundaresan et 
al. demonstrated that platelet-derived growth factor stimulates production of ROS upon ligand binding, 
and these ROS are responsible for inducing appropriate cellular responses (1995).  Binding of another 
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peptide, epidermal growth factor (EGF), increased intracellular ROS concentrations.  Addition of 
catalase, a H2O2 scavenger, inhibited the cell’s downstream responses to EGF binding (Bae et al., 1997).  
It is postulated that ROS signaling evolved as a mechanism for communication between metabolism and 
other cellular processes (Sena and Chandel, 2012).  
Oxidation of sulfhydryl (−SH) groups to sulphenic acid (−SOH) is followed by two distinct 
pathways.  Further oxidation can irreversibly modify the sulfenic acid to a sulfinic (−SO2H) or sulfonic 
(−SO3H) acid.  The oxidized cysteine could instead form a disulfide bridge (−SS−) or a sulfenyl amide 
(−SN−) with nearby thiols or nitrogens.  These new covalent bonds cause conformational changes that 
may affect the activity of the protein.  However, disulfide bridges protect cysteines from irreversible 
oxidation; thioredoxins (Trx) are able to reduce disulfides and regenerate reduced dimers (Janssen-
Heininger et al., 2008).  Restoring protein structure and function via formation of reversible disulfide 
linkages is a key mechanism of ROS signaling. 
 
Changing the redox state of a protein affects activity (Giles et al., 2003).  As the sulfur of 
cysteine can occur in 10 different oxidation states (Jacob et al., 2003), cysteine oxidation can result in 
unique functional outcomes.  Oxidation can activate or inactivate a signaling protein, as with Ras and 
Figure 1. Oxidation of sulfhydryls.  Cysteines (A) are initially oxidized to a sulphenic acid (B).  The formation of a 
mixed disulfide (C) with another thiol allows for the regeneration of the reduced cysteine and protects the thiol 
from irreversible modification to a sulfinic (D) or sulfonic (E) acid.   
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protein tyrosine phosphatase respectively (Janssen-Heininger et al., 2008; Kwon et al., 2004).  Heat 
shock proteins multimerize upon thiol oxidation, whereas glucokinase dissociates (Ahn and Thiele, 
2003; Rizzo and Piston, 2003).  Thus, all of these factors illustrate that ROS-mediated signaling 
pathways are regulated and specific processes.   
Redox Environment 
The intracellular redox environment is 
maintained by low molecular weight thiols.  
Chief among these small molecules is 
glutathione (GSH), a tripeptide of glutamic acid, 
cysteine, and glycine with an atypical, gamma 
peptide linkage between the carboxyl of Glu and 
the amine of Cys (Figure 2).  Glutathione is the most abundant free thiol in eukaryotic cells (Poole, 
2015).  Reduced GSH modulates oxidative stress through the formation of disulfide linkages (GSSG).  
Indeed, the GSH:GSSG is indicative of intracellular redox state.  
Careful regulation of intracellular redox conditions is critical for homeostasis.  Different cellular 
components have different redox needs; glutathione is able to accommodate a range of redox 
environments.  GSH has distinct concentrations and redox states for different cellular compartments.  
Circu and Aw define four major regions of unique glutathione conditions: the cytosol, the mitochondria, 
the nucleus, and the endoplasmic reticulum (2010).  In the cytosol, a reducing environment is key for 
proper protein function.  Therefore, glutathione concentrations are high, ranging from 2-10 mM.  The 
GSH:GSSG ratio is dynamic, rapidly responding to changes in the oxidative environment, however, it 
usually exceeds 100 to 1.  As the mitochondria are the major endogenous source of ROS, more GSH is 
necessary to form protective disulfides and insulate proteins from ROS. The mitochondria, therefore, 
Figure 2. Structure of glutathione (GSH).		
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have a higher concentration of glutathione, usually ranging from 5-10 mM.  Nuclear glutathione 
concentrations are less understood, but are considered more dynamic because nuclear GSH fluctuates 
with the cell cycle (Markovic et al., 2007).  The endoplasmic reticulum has total GSH concentrations 
similar to the cytosol, yet GSSG is more abundant.  Disulfide bonds are often key to proper protein 
folding, and GSSG encourages the formation of these linkages. The ratio of reduced glutathione to 
oxidized glutathione is considered to be about 3 to 1 (Bass et al., 2004), though this finding has recently 
come under question (Dixon et al., 2008).  Each cellular compartment has a unique function that 
coincides with a unique redox environment, and the GSH/GSSG redox couple is a central buffer for the 
maintenance of homeostasis. Glutathione and other small thiols modulate the redox balance by forming 
protective disulfides with other peptides or proteins.   
  
Glutathione works in tandem with other redox proteins.  Thioredoxins (Trx) are small, 
ubiquitous proteins with two catalytic, redox-active cysteines in a conserved sequence: Cys-Gly-Pro-Cys 
(Nakamura et al., 1997).  As previously mentioned, Trxs catalyze the reduction of protein disulfide 
bonds, thus restoring protein structure and activity.  When one cysteine is oxidized to a sulfenic acid, the 
other cysteine reacts and forms a disulfide bond, thus resolving the oxidation.  Peroxiredoxins (Prxs), 
another antioxidant enzyme, also has two catalytic cysteines that function similarly.  Prx and glutathione 
Figure 3. Glutathione oxidation and reduction.  GR (Glutathione reductase); NADPH (Nicotinamide adenine 
dinucleotide phosphate). 	
GSH	 GSSG	
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peroxidases (Gpx) detoxify H2O2.  A synergistic relationship exists between these two enzymes in 
which, at high H2O2 concentrations, a portion of each antioxidant enzyme remains in the oxidized form, 
and the reactivity of both Gpx and Prx is increased (Molavian et al., 2015).  The fact that two seemingly 
independent proteins would be affected by the concentration of another enzyme reflects the intricacy of 
cellular redox mechanisms.   
Cysteines as Reactive Species 
 Though cysteines have a low abundance in protein structures, they often play a critical role in 
modulating enzyme function and binding properties (Poole, 2015).  Cysteine residues engage in unique 
reactions due to their innate chemical properties.  The amino acid’s nucleophilicity, redox activity, and 
metal binding properties make cysteines a critical regulatory component of many proteins (Giles et al., 
2003).  
  Thiol groups are vulnerable to deprotonation.  The relative ratio of thiol (−SH) to thiolate anion 
(−S-) varies according to the pH.  In proteins, cysteine has an average pKa of 8.3 (Berg et al., 2012).  
However, the local microenvironment can greatly influence an amino acid’s pKa.   Stabilization of the 
thiolate anion with nearby positive residues can lower the pKa, whereas hydrophobic environments 
favor the amino acid’s neutral form and can thus increase the pKa.  Indeed, protein cysteine pKa values 
in the literature vary from 2.5 to 11.1 (Pace et al., 2009).    
Certain cysteine residues have a pKa of 4 or lower, meaning the amino acid exists primarily as a 
thiolate anion at physiological pH.  Indeed, many enzymes have a catalytic cysteine that functions as a 
protease.  This mechanism involves deprotonation of a cysteine by a nearby basic residue, typically 
histidine.  The thiol anion initiates a nucleophilic attack on the carbonyl carbon of the peptide backbone, 
resulting in its cleavage (Berg et al., 2012).  Their critical role in an enzyme’s catalytic behavior makes 
cysteines a highly conserved residue.  In areas where cysteines are conserved, the degree of conservation 
10	
often exceeds 90% (Marino and Gladyshev, 2010).  Highly conserved cysteines are typically buried in 
the protein’s hydrophobic core (Rose et al., 1985).  The degree of burial varies; however, these thiol 
groups are insulated from solvent interactions (Janin, 1979) and are more likely to be found near other 
cysteines (Marino and Gladyshev, 2010).  It is likely that these proximal cysteines are able to form 
disulfide bridges to modulate protein activity in response to ROS or to associate with metals in sulfur 
clusters.  Clustered cysteines are associated with redox sensitivity and metal binding (Marino and 
Gladyshev, 2010).   
On the other hand, areas of poor cysteine conservation usually have less than a 10% rate of 
conservation (Marino and Gladyshev, 2010).  These cysteines tend to be near the protein’s surface and 
interact directly with the solvent (Marino and Gladyshev, 2010).  Indeed, there seems to be an 
evolutionary bias against surface-exposed, unpaired cysteines (Beeby et al., 2005).  Given the inherent 
reactivity of sulfur, this finding is not surprising.   
Cysteines have low redox potential, reported as a range from -270 mV to -125 mV (Giles et al., 
2003).  This allows cysteines to function as an electron donor and to facilitate electron transfer.  For 
example, glutathione reductase (GR) functions by transferring two electrons from NADPH to oxidized 
glutathione (Berg et al., 2012).  This electron transfer reduces GSSG to two equivalents of GSH.  
Cysteine’s low redox potential allows proteins to modulate diverse cellular conditions through the 
transfer of electrons and the formation of disulfide bridges. 
Cysteines have unique metal binding properties.  Because of the range of oxidation states it can 
assume, Giles et al. refer to sulfur as a storage facility for metal ions (Giles et al., 2003).  Indeed, sulfur 
can accommodate a large number of bonds by changing its geometry.  Iron-sulfur clusters are 
particularly important in biochemistry.  They are often implicated in electron transfer reactions as both 
Fe and S are able to adapt numerous electronic configurations thus “accepting, donating, shifting, and 
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storing electrons” according to Beinert et al. (1997).  Fe-S clusters even serve as redox sensors; 
oxidation of [Fe2S2]1+ to [Fe2S2]2+ results in the activation of intracellular detoxifying mechanisms in E. 
coli (Gaudu and Weiss, 1996).  Beyond redox functions, iron-sulfur clusters have been found to stabilize 
radicals, initiate dimerization, stabilize binding sites, and protect against protease attack (Beinert et al., 
1997).  Iron-sulfur clusters are critical to many biochemical reactions.  The unique properties of 
cysteines, coupled with transition metals like iron, allow its participation in a wide array of critical 
pathways.  
Glycolysis 
Glycolysis is one of the oldest biochemical processes.  It is the central metabolic pathway in 
prokaryotes and eukaryotes.  Through glycolysis, one molecule of glucose is converted into two 
molecules of pyruvate with the concomitant net production of two molecules of ATP.  Pyruvate can then 
be funneled into other biochemical pathways such as the Citric Acid Cycle for large-scale ATP 
production or to fermentation to regenerate glycolytic cofactors.  ATP production in glycolysis, though 
minimal, is independent of oxygen, making glycolysis an important biochemical pathway in anaerobic 
environments. 
Glycolysis consists of ten reactions and can be divided into two major stages.  First, glucose is 
broken down.  Then, ATP is harvested through the oxidation of glucose fragments to pyruvate.  
Pyruvate kinase (PK) is a key glycolytic enzyme that catalyzes the final, rate-limiting step in glycolysis, 
the conversion of phosphoenolpyruvate (PEP) to pyruvate with the concurrent generation of one 
molecule of ATP.   The ninth step of glycolysis generates the thermodynamically unstable PEP.  PK 
catalyzes the nucleophilic attack of the β-phosphoryl oxygen of ADP on PEP.  This reaction generates 
ATP and enolpyruvate; enolpyruvate then tautomerizes to form the more thermodynamically stable 
pyruvate.  Lys-269 in PK’s active site stabilizes the intermediate as the phosphoryl group of PEP is 
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directly transferred to ADP (Iqbal et al., 2014).   Enolpyruvate tautomerizes after receiving a proton 
from a water molecule bound to Thr-327 and Ser-361 (Israelsen and Vander Heiden, 2015).  The driving 
force of the reaction is the tautomerization; its high free energy loss allows for the coupling of a more 
unfavorable reaction, in this case, the generation of ATP from ADP (McKee and McKee, 2012).  
Because of the highly negative ∆G, this reaction is irreversible and highly regulated.  
Pyruvate Kinase 
Pyruvate kinase (PK) is a 
homotetramer of 237 kDa; each 
identical subunit is about 57 kDa 
and consists of 530 amino acid 
residues (Cottam et al., 1969).  
Each monomer has one active site 
and consists of four major 
domains: the N-terminus, Domain 
A, Domain B, and Domain C (Ou 
et al., 2010).  Larsen et al. defined 
the N-terminus’s structure as a 
helix-turn-helix, and it represents residues 1-42 (1997).  Domain A, consisting of residues 43-115 and 
219-387, is the most highly conserved (Muirhead et al., 1986).  It is arranged in a (β/α)8-barrel, a 
common enzymatic motif.  In this structure, eight parallel β-strands form a cylinder that is encased in a 
wheel of eight α-helices (Vega et al., 2003).  Domain B (residues 116-218) is the least conserved.  It is a 
nine-stranded β-barrel that protrudes into the solvent (Larsen et al., 1994).  Residues 388-530 arranged 
Figure 4. Structure of pyruvate kinase monomer (PK).  This enzyme 
consists of four major domains: Domain N-terminus (red), Domain A 
(green), Domain B (yellow), and Domain C (blue).  Coordinated ions 
(Mn2+ and K+) are in the active site (orange).  Drawn from 1PKN.pdb 
13	
in five α-helices and five β-sheets form Domain C.  This domain is implicated in the enzyme’s 
tetramerization.   
PK Activity 
PK’s active site lies at 
the cleft between Domains A 
and B.  A flexible hinge allows 
PK to modulate its activity.  In 
its inactive T-state, the cleft is 
open; activation of the enzyme 
closes the cleft (Consler and 
Lee, 1988).   X-ray 
crystallography studies by Larsen 
et al. reveal that Domain B’s backbone rotates more than 20° with respect to Domain A to open or close 
the active site (1997).  Furthermore, Larsen et al. warn that assuming PK only has two states - open or 
closed - is a little simplistic.  Indeed, subunits adopt different orientations with varied activities in 
response to allosteric effectors. 
Cations are required for PK’s activity.  Two equivalents of Mg2+ and one equivalent of K+ are 
typically coordinated to the active enzyme.  Binding of cations engenders conformational changes; Ou et 
al. specify that the coordinated enzyme-metal complex has a different conformation than free enzyme 
(2010).  Divalent magnesium ions assist in the orientation of PEP and ADP (Muirhead et al., 1986).  
Their positive charges minimize the electrostatic repulsion resulting from three highly charged 
phosphoryl groups being held in close proximity.  One magnesium cation binds PK and the nucleotide 
Figure 5. Structure of pyruvate kinase tetramer (PK). Domain N-terminus 
(red), Domain A (green), Domain B (yellow), and Domain C (blue).  Drawn 
from 1A49.pdb 
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substrate (ATP or ADP), while the other Mg2+ holds PK and PEP (Larsen et al., 1994).    Critical 
residues for Mg2+ coordination are the carboxyl groups of Glu-271, Ala-292,Arg-293, and Asp-295 
(Muirhead et al., 1986).  The γ-phosphate group of ATP forms a bridge between the two divalent cations 
(Lodato and Reed, 1987).  
The monovalent 
cation is also essential for 
maximum enzymatic 
activity (Kachmar and 
Boyer, 1953).  Without K+, 
PEP must be bound first.  
Binding of K+ allows the 
enzyme to proceed in a 
random order mechanism 
(Oria-Hernández et al., 2005).  Monovalent potassium allows PEP and ADP to bind independently, thus 
making the Vmax of the K+-PK-complex 400 times higher than wild type PK (Oria-Hernández et al., 
2005).   The cation changes the orientation of the residues that bind the substrates, namely Glu-363 and 
Gln-328.  Monovalent potassium is coordinated to the carbonyl of Thr-113 and the oxygens of Ser-76, 
Asn-74, and Asp-112 (Larsen et al., 1997) 
PK’s active site has unique properties and is finely tuned to labilize γ-phosphate groups and 
stabilize enolpyruvate.  PK has been implicated in other, similar reactions including the decarboxylation 
of oxaloacetate, the enolization of pyruvate, and the ATP-dependent phosphorylation of α-hydroy or α-
thio carboxylates (Creighton and Rose, 1976; Rose, 1960; Ash et al., 1984).  Key residues in the active 
site create favorable interactions with these high-energy substrates.  Coordinated mono- and divalent 
Figure 6. Active site of PK with ions.  Domain B has been removed, so the viewer is 
looking down the (β/α)8-barrel of Domain A.  Mn2+ is coordinated to pyruvate 
(magenta) at Glu-271, Arg-293 and Asp-295.  K+ is coordinated to Asn-74, Ser-76, 
Asp-112, and Thr-113.  Ions (red), residues coordinated to ions (yellow), residues 
holding H2O (blue).  Drawn from 1PKN.pdb 
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ions further mitigate destabilizing electrostatic forces.   
PK Isozymes 
Mammals have two genes for PK that encode four isoforms: L, R, M1, and M2.  The expression 
of a specific isozyme is dependent on the energetic needs of the surrounding tissue; tissues preferentially 
express one PK isoform (Urich, 2013).  In sites of gluconeogenesis, such as the liver, the L isozyme is 
expressed.  The R isozyme is found only in red blood cells.  Brain and heart cells express PK-M1, and 
fetal and proliferating tissues express PK-M2.   
Alternative splicing of the PKM gene leads to the formation of M1 or M2 (Noguchi et al., 1986).  
Though these isoforms differ by only 22 of 531 amino acids, their activity is quite different.  PK-M1 is 
locked in the catalytically active R-state, and it exists as a stable tetramer (Corder et al., 1989; Israelsen 
and Vander Heiden, 2015). PK-M1 undergoes hyperbolic kinetics and is not allosterically regulated 
(Ikeda and Noguchi, 1998).  On the other hand, PK-M2 requires fructose-1,6-bisphosphate (FBP), an 
allosteric activator, to transition from a dimer to a tetramer. Additionally, PK-M2 undergoes sigmoidal 
kinetics and is allosterically regulated (Berg et al., 2012).  As microorganisms do not express PK-M1, it 
is believed that this isoform is an evolutionary adaptation for specialized energy production in specific 
tissues like the heart and brain (Ikeda et al., 1997).  These tissues are critical for an organism’s survival 
and have a constant need for ATP.  Therefore, expressing a form of PK that is always active provides a 
continuous stream of energy to perform essential life functions.    
The differences in the primary sequence of PK-M1 and PK-M2 lie at the inter-subunit junction, 
located in Domain C.  This area controls the association of inactive PK dimers into catalytically active 
PK tetramers.  Several residues have been identified as researchers seek an explanation of the 
differential allosteric properties between the isoforms.  PK-M1 has a highly conserved glutamic acid at 
residue 432, whereas PK-M2 has either a threonine or a lysine (Ikeda et al., 2000).  The negative charge 
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of the glutamic acid creates a repulsive electrostatic interaction with the negative phosphate groups of 
FBP.  This repulsion destabilizes FBP’s binding and is critical in PK-M1’s lack of allosteric regulation.  
Cys-423 in PK-M2 has been found to destabilize the R-state of the protein (Ikeda and Noguchi, 1998).  
It is deprotonated and thus disrupts the hydrophobic interactions of the enzyme’s core.  PK-M1 has a 
hydrophobic leucine at this position; the hydrophobic stabilization at the inter-subunit contact allows the 
M1 isozyme to exist as a stable tetramer (R-state).  Indeed, when Leu-423 is replaced with cysteine, the 
mutated PK-M1 exhibits allosteric regulation similar to wild-type PK-M2 (Ikeda and Noguchi, 1998).  
Different amino acids along the inter-subunit domain affect the electrostatic profiles of PK-M1 and M2 
and account for the isozymes’s dissimilar activity and regulation. 
PK Regulation 
Due to its placement at a key biochemical branching point, PK modulates the glycolytic flux.  
When PK is abundant and active in a cellular milieu, aerobic metabolism is promoted. Glycolytic 
intermediates are funneled towards the production of ATP.  Conversely, when PK is scarce or 
inactivated, glucose, the key intracellular carbon source, is used to construct larger biological molecules 
like nucleic acids, lipids, and amino acids.  PK’s activity thus controls the relative rates of metabolism 
and anabolism.   Because this ratio is critical to cellular homeostasis, PK is highly regulated through its 
quaternary structure and allosteric regulators.    
Structural Regulation 
The organization of PK’s subunits into either a tetramer or a dimer affords a dynamic regulation 
of its activity.  As a tetramer, PK has a high PEP affinity and is active; it promotes energy metabolism 
through the catalysis of the final step in glycolysis.  Conversely, as a dimer, PK has a low affinity for 
PEP and is catalytically inactive.  The dimer form shunts glucose towards macromolecule synthesis.  
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Dimerized PK may not participate in glycolysis, but it does function as an active protein kinase.  This 
form of PK is implicated in signaling and gene transcription processes.  Dimerized PK phosphorylates 
key proteins involved in proliferation processes.  For example, this enzyme interacts with and 
phosphorylates histone H3 at Thr-11.  Phosphorylated H3 T11 is implicated in cell proliferation and 
tumorigenesis (Yang et al., 2012).   
The ratio between tetramerized and dimerized PK is controlled by numerous factors including 
post-translational modifications and allosteric effectors.  Post-translational modifications include the 
addition of phosphate or lipid groups to amino acid residues. For example, in cancerous cells, oncogenic 
tyrosine kinases phosphorylate Tyr-105.  The addition of a phosphate group at this residue causes the 
release of FBP, which leads to the formation of the inactive dimer (Iqbal et al., 2014). 
Anastasiou et al. (2011) found that oxidation of Cys-358 also results in PK inactivation and the 
re-routing of glycolytic intermediates to the pentose phosphate pathway.  The pentose phosphate 
pathway stimulates the formation of NADPH, an important cofactor for the maintenance of the cellular 
redox environment.  Higher concentrations of NADPH allow for glutathione reductase (GR) to 
catalytically reduce glutathione.  Reduction of glutathione increases the reducing potential of the cell 
and alleviates the oxidative environment that caused the initial thiol oxidation.  Therefore, Cys-358 
oxidation initiates a cascade that results in the generation of reductive species like GSH and the 
restoration of the cell’s reducing environment.  This process is particularly important in cancerous cells 
because of their inherent oxidative state; oncogenic cells generate high levels of ROS because of 
hypoxia, matrix detachment, mitochondrial dysfunction, and inflammation (Anastasiou et al., 2011).  
These cells are often starved for nutrients as tumor growth outpaces angiogenesis (Wellen and 
Thompson, 2010).  However, detoxification with GSH is critical for all cells.  PK acts as a redox-switch; 
its inactivation stimulates the production of NADPH and other potent reducing factors to maintain the 
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intracellular redox environment.   
Allosteric Regulation 
PK-M2 is regulated by FBP, an upstream metabolite.  As previously discussed, FBP promotes 
PK-M2 tetramerization and stabilizes the protein’s active state.  FBP generation is highly regulated, so 
an abundance of FBP indicates that the cell has committed to glycolysis (McKee and McKee, 2012).  
PK-M2 activity is increased to funnel these metabolites towards ATP production.  Low levels of FBP 
indicate that the cell is not promoting glycolysis, so PK-M2 activity is diminished.  FBP binds about 40 
Å away from the active site (Jurica et al., 1998).  However, its binding invokes significant changes in 
the protein’s structure.  Allosteric binding of FBP causes PK-M2 to transition from its inactive T-state to 
its active R-state.  This transition results from the concerted rotation of each of the 12 domains of the 
tetramer, modifying the geometry of 
the allosteric, FBP binding site and 
the active site (Mattevi et al., 1996).   
In addition to changing PK-M2’s 
quaternary structure, FBP increases 
PEP’s binding affinity, thus 
increasing catalysis.  Intracellular 
levels of FBP assist in determining 
the glycolytic flux.  
 The FBP binding pocket is 
located in Domain C.  When FBP is bound, the ligand is almost completely buried in the pocket created 
by residues 402-407.  Jurica et al. analyzed FBP binding in S. cerevisiae and determined its coordination 
to the protein’s primary structure (1998).  Each monomer of PK-M2 binds one FBP, and there is a 
Figure 7. FBP binding site in S. cerevisiae  PK.  FBP (magenta), 
coordinated residues (blue), Ser-433 (green).  Drawn from 1A3W.pdb 
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strong, stabilizing salt bridge formed between Arg-429 and a negatively charged phosphoryl group of 
FBP (Valentini et al., 2000).  Hydrogen bonds from polar amino acids (Ser-402, Ser-404, and Thr-407) 
and π-stacking with Trp-452 further stabilize FBP’s binding to PK-M2.  
ATP is a downstream allosteric 
inhibitor of PK activity (Berg et al., 
2012).  High intracellular ATP levels 
indicate that the cell does not need to use 
glucose for catabolism because the cell 
already has excess energy.  ATP acts as 
an allosteric inhibitor by competing with 
ADP for access to PK’s shared active 
site.  Reynard et al. found that ATP 
inhibited binding of both ADP and PEP 
(1960).  The enzyme proceeds via a direct phosphoryl transfer between the two substrates, so the 
presence of ATP in the active site precludes binding of other species.  Indeed, ATP decreases Vmax and 
has a low Ki, indicating competitive inhibition (Holmsen and Storm, 1968).  The structure of PK’s active 
site and its catalytic mechanism allow for dynamic modulation of the enzyme’s activity using 
downstream products like ATP.   
Other notable allosteric effectors include phenylalanine, alanine, and serine.  Phenylalanine is 
unique in that it affects both PK-M1 and M2 (Israelsen and Vander Heiden, 2015).  Phenylalanine binds 
at a location distinct from the active site and decreases the enzyme’s affinity for PEP by loosening the 
overall quaternary structure (Yu et al., 2003).  PK becomes more asymmetric as interatomic distances 
expand up to 110 Å (Yu et al., 2003).   However, despite this expansion, the protein remains a tetramer 
Figure 8. Direct phosphoryl transfer in PK’s active site. Adapted 
from Reynard et al., 1960. 
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(Oberfelder et al., 1984).  Alanine also inhibits PK-M2 
activity.  It binds in the same location as phenylalanine 
(Domain C: Ile-468 and His-463), but it does not 
engender dramatic conformational changes (Williams 
et al., 2006).  Instead, alanine favors PK’s inactive 
dimer.  Alanine is one of the first amino acids produced 
as proteins are degraded; indeed, alanine can be 
synthesized from pyruvate in one step (Berg et al., 
2012).  Therefore, an abundance of alanine signals a 
shift in the cell’s glycolytic flux from metabolism to 
anabolism; alanine binding adjusts PK’s activity to 
accommodate this trend.  Serine acts as an allosteric 
activator of PK.  This  
amino acid is implicated in biosynthesis of macromolecules for proliferation; high levels of 
serine indicate that glycolytic intermediates have been funneled 
towards anabolism (Ye et al., 2012).  Therefore, serine 
allosterically binds and activates PK in a feedback loop that 
ensures the continued production of metabolic molecules to fuel 
cell processes.  Interestingly, Yang et al. proposed a synergistic 
allosteric mechanism for FBP and serine binding; like FBP, 
serine increases the binding affinity of PK-M2 for PEP (2016).  Each allosteric activator engages in 
significant hydrogen bonding with PK-M2, and the binding free energy of FBP/Ser/PK-M2 is lower than 
their individual binding free energies of FBP/PK-M2 and Ser/PK-M2 (Yang et al., 2016).  Allosteric 
Activators Inhibitors 
FBP ATP 
Serine Phenylalanine 
 Alanine 
Figure 9.  Binding sites for PK (tetramer).  Active 
site (PEP and ADP/ATP binding site; red), FBP 
binding site (blue), amino acid binding site (pink).  
Enzyme is rotated 90°. Drawn from 1A49.pdb. 
Table 1. Allosteric Regulators of PK. 
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factors represent dynamic, rapid, and reversible methods to modulate PK activity in response to diverse 
stimuli.   
 
Research Goals 
The goal of this research is to elucidate the extent of cysteine modification of PK under various 
models of intracellular conditions.  Notably, this research is focused on understanding the effects of 
oxidant treatment on PK’s activity and conformation.  This research has been completed in tandem with 
Julia Zuercher to enhance the breadth of realized research goals.   
Julia focused on activity assays.  Using an Absorbance Microplate Reader (BioTek Instruments, 
Winooski, VT), Julia determined PK activity by monitoring changes in absorbance at 340 nm, the 
absorbance wavelength of NADH. She coupled PK’s phosphoryl transfer from PEP to ADP with 
homolactic fermentation.  Lactate dehydrogenase (LDH) catalyzes the regeneration of NAD+ via the 
reduction of pyruvate to lactate.  Julia was able to determine PK activity by monitoring the decrease in 
absorbance at 340 nm as NADH was oxidized to NAD+.   
 
 
 
 Julia’s activity assays were coupled with spectrophotometric determinations of the effects of 
various treatments on cysteine reactivity and accessibility within PK.  Cysteines are critical residues in 
proteins that affect catalytic activity and protein conformation.  5-Iodoacetamidofluorescein (IAF) reacts 
Figure 10. PK-LDH Coupled Reaction.  
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with reduced thiol groups and binds a fluorescent tag that can be 
detected using SDS-PAGE and absorbance assays.  The thioether bond 
formed between the cysteine and IAF is stable at physiological pH and 
at room temperature.  The stability of the fluorescent tag and the 
physiologically relevant reaction conditions make IAF labeling a potent 
technique for quantifying cysteine reactivity (Landino et al., 2011).      
After PK was subjected to different treatments, IAF in DMF 
was added to the sample to quantify the number of accessible sulfhydryls remaining in the protein.  
Treatments included the addition of oxidants and allosteric regulators, both of which affect the ability of 
IAF to tag cysteines.  Oxidation can result in the formation of disulfide bridges, rendering the cysteine 
inaccessible to IAF tags.  The binding of allosteric regulators may block cysteines.  Therefore, 
measuring the extent of IAF tagging via SDS-PAGE or absorbance measurements allows researchers to 
determine and quantify the fate of reactive cysteines in various intracellular conditions.   
 
 
Figure 12. IAF Tagging of Cysteines. 
Figure 11. Structure of 5-
Iodoacetamidofluorescein (IAF).	
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Methods and Materials 
Materials 
Pyruvate kinase from rabbit muscle (PK-M2), HOCl, 5-(Iodoacetamido)fluorescein (IAF), 
disodium salt of ATP, trisodium salt of PEP, and 5,5′-Dithiobis(2-nitrobenzoic acid) (DTNB) were 
obtained from Sigma-Aldrich.  Guanidine hydrochloride, ammonium persulfate, and TEMED were 
purchased from Fisher Scientific.  FBP was purchased from Alfa Aesar.  Ethyl alcohol was obtained 
from Pharmco-Aaper.    
Protein Purification  
Pyruvate kinase from rabbit muscle (PK-M2) was obtained as a suspension in an ammonium 
sulfate solution (3.2 M (NH4)2SO4 solution, pH 6) (Type II) or as a lyophilized powder (Type III).  PK-
M2 aliquots of known concentration were created to ensure reproducibility of assays.   
PK suspended in ammonium sulfate solution was purified using a desalting column.   Econo-Pac 
10DG columns (Bio-Rad Laboratories, Munich, Germany) were used with a buffer solution.  This 
column’s polyacrylamide gel matrix excluded molecules larger than 6,000 daltons. PK, with a subunit 
weight of 57 kDa, was excluded, while salt impurities from the suspension were trapped in the 
matrix.  PK was added to the column in small volumes after the sodium azide preservative buffer was 
poured off and the column was equilibrated to the buffer.  Fractional volumes were collected of the 
species of interest. 
Concentrations of purified PK-M2 were determined using extinction coefficients.  Proteins and 
peptides have a unique UV-light absorptivity owing to their primary structure; aromatic amino acids 
absorb around 280 nm.  Manipulation of Beer’s Law allows for the determination of a sample’s protein 
concentration.  
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where  c is the concentration of the protein sample, A280 is the solution’s absorbance measured at 280 
nm, and ε is the protein’s extinction coefficient, established as 0.54 mL/(mg*cm) from the literature 
(Boyer, 1962).   
Oxidation of Samples  
Protein samples were removed from the -80° C freezer and kept on ice during sample 
preparation.  HOCl was prepared using aliquots from a stock solution.   PK (7.6 µM) was added to 0.1 
M Phosphate buffer pH 7.4.  Samples were incubated for 10 minutes at room temperature with a 
concentration of HOCl prepared from the stock.  The total reaction volume was 15 µL.  After 10 
minutes, 1.4 mM IAF was added to the solution.  Samples were incubated for 30 minutes at 37° C 
(Fisher Scientific, Dubuque, IA).   
Addition of Allosteric Effectors    
Allosteric effectors were added to the samples prior to oxidation.  The samples were incubated 
with the substrates for 10-15 minutes at room temperature, then HOCl concentrations were added.  The 
remainder of the procedure followed the oxidation protocol.   
Absorbance Measurements  
To measure absorbance, 120 µL (four times the reaction volume) of 100% EtOH was added to 
each sample after incubation with IAF.  Samples were then frozen for at least 2 hours, sometimes 
overnight, at -20°C.    
Samples were removed from the freezer and centrifuged at 12,000 rpm for 15 minutes.  The 
supernatant was removed, and the samples were washed with 150 µL of 80% EtOH.  Samples were left 
25	
for 10 minutes on ice, then re-centrifuged.  This washing process was repeated until the supernatant was 
no longer fluorescent, as verified by a black light (UVP, Upland, CA).  The non-fluorescent supernatant 
was removed and the samples were allowed to dry.  The protein pellet was resuspended in 6M guanidine 
HCl pH 8.8.   
 Protein absorbance was measured using a UV/VIS spectrophotometer (OceanOptics, 
USB2000).  Quartz cuvettes (Starna Cells, Atascadero, CA) were used, and guanidine HCl was used as 
the blank for the absorbance measures.  Absorbance values were recorded at the wavelength of interest, 
and the peaks were stored for comparison among samples.   
SDS-PAGE  
Gels were prepared using Mini-PROTEAN Tetra Cell equipment (Bio-Rad Laboratories, 
Munich, Germany).  A 7.5% separating gel was prepared using deionized water, 1.5 M Tris buffer pH 
8.8, and 30% acrylamide.  This solution was degased under vacuum and thoroughly mixed.  Addition of 
10% SDS, ammonium persulfate, and TEMED initiated polymerization.  The mixture was added to the 
assembled gel cassette and overlaid with a small amount of water-saturated butanol. 
After polymerization (20-30 minutes), the butanol was rinsed off, the gel was dried, the well 
combs were positioned, and the stacking gel was added.  The stacking gel was prepared using deionized 
water, 0.5 M Tris buffer pH 6.8, 30% acrylamide, 10% SDS, ammonium persulfate, and 
TEMED.   Standard mixtures used for gel preparation are found in the appendix.   The stacking gel 
polymerized (15-20 minutes), and the well combs were removed.  Wells were rinsed with deionized 
water, and the gel plates were mounted in the Mini-PROTEAN Tetra Cell assembly.  Running buffer 
was added to the mini tank.   
 To perform gel electrophoresis, 16 µL of SB (+) was added to each microcentrifuge tube after 
incubation with IAF.   Solutions were then loaded into wells.  Gels were run for 90 minutes at 90 V.  
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The gels were removed from the mounts and rinsed.  Fluorescence measures were taken on ChemiDoc 
XRS+ Imaging System (Bio-Rad Laboratories, Munich, Germany).  Integration software provided by 
ImageLab was used to quantify fluorescence.   
DTNB Assay 
DTNB was used to verify that PK-M2’s cysteines are accessible to small molecule labeling.  
DTNB reacts with reduced thiols to form a mixed disulfide and TNB2-, a molecule that absorbs at 412 
nm (Figure 13).  PK (14.4 µM) was added to 0.1 M Phosphate buffer pH 7.4.  The concentration of 
cysteines was calculated (~130 µM cys), and ten times this concentration of DTNB (1.3 mM) was added 
to the solution.  The total reaction volume was about 20 µL.  After reaction, the sample was diluted to 
100 µL with buffer.  The diluted sample was pipetted into a quartz cuvette and absorbance measures 
were taken at 325 nm (absorbance of DTNB) and 412 nm (absorbance of TNB2-) on a UV/VIS 
spectrophotometer (OceanOptics, USB2000) to determine the extent of reaction.   
	Figure 13. Reaction of DTNB with thiol (R-S).  The reaction can be monitored at 412 nm to determine the extent of 
TNB2- generation. The formation of TNB2- causes a color change; the clear solution becomes pale yellow as TNB2- 
is generated.   
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Figure 14. Effects of Oxidation on PK-M2 Activity (Zuercher, 2017).  PK-M2 activity is measured as a 
decrease in absorbance at 340 nm as NADH is oxidized to NAD+.  Oxidation by HOCl decreases PK-M2’s 
activity. 
Results 
Oxidation Inhibits PK-M2 Activity and IAF Labeling 
Julia measured PK-M2 activity in response to oxidant treatment. HOCl was added to the reaction 
mixture after the addition of PK-M2.  PK-M2 activity was measured as a percent change in absorbance 
at 340 nm over 5 minutes.  At 0 µM HOCl, the absorbance at 340 nm decreases by about 90%, 
representing the full extent of PK activity in this system.  The addition of HOCl results in less 
generation of NAD+, as determined by less of a total change in absorbance at 340 nm.  Lower 
concentrations of HOCl do not have an appreciable effect on enzymatic function.  However, as the 
concentration of oxidant in the reaction mixture exceeds 100 µM, the protein becomes inactive.  PK 
activity continues to decrease as the concentration of oxidant increases past 100 µM. 
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Oxidation also decreases the extent of IAF tagging of PK-M2.  SDS-PAGE shows a clear 
decrease in fluorescence as the concentration of HOCl increases.  At 0 µM HOCl, maximum IAF 
tagging is attained for this system.  Addition of increasing concentrations of HOCl decreases the extent 
of IAF labeling of PK-M2’s cysteines.   
 
 
 
 
 
Absorbance measurements allow for a more quantitative determination of cysteine reactivity.  At 
498 nm, HOCl concentration has an inverse relationship with absorbance intensity.   
 
	 	 	
 
 
Figure 15. Oxidation Inhibits IAF Tagging: Gel.  IAF reacts with reduced thiols to form a stable fluorescent 
tag.  Oxidation of PK with HOCl reduces the number of accessible sulfhydryl residues and inhibits IAF 
tagging. 
Figure 16. Oxidation Inhibits IAF Tagging: Absorbance Spectra.  IAF reacts with reduced thiols to form a 
stable tag that absorbs at 498 nm.  Oxidation of PK-M2 with HOCl reduces the number of accessible 
sulfhydryl residues and inhibits IAF tagging.  
0 µM 
HOCl	 50 µM HOCl	 100 µM HOCl	
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Figure 18. Ions Inhibit IAF Tagging: Gel Summary.  Average fluorescent intensity obtained from SDS-
PAGE was converted to a percent of the control.  Values displayed above represent the average of four 
trials.  Addition of ions reduces the extent of IAF tagging across oxidative environments. 
	
Ions Protect PK-M2 from IAF Tagging 
PK-M2 requires ions for activity, and these ions have been shown to exert a protective effect 
against oxidation and IAF tagging.  Ions (100 mM KCl and 10 mM MgSO4) were added to the 0.1 M 
Phosphate buffer pH 7.4.  SDS-PAGE show a decrease in the extent of IAF labeling with the addition of 
ions.  IAF tagging was lower for samples with ions than samples without ions at 0, 50, and 100 µM 
HOCl. 
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Figure 17. Ions Inhibit IAF Tagging: Gel.  IAF reacts with reduced thiols to form a stable fluorescent tag.  
Addition of ions reduces the extent of IAF labeling across oxidative environments. 
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Samples with ions have a lower absorbance at 498 nm than samples without ions, indicating that 
ions decrease the extent of IAF labeling of PK-M2.  At 0 µM HOCl, the extent of IAF labeling was 
similar for samples with and without ions.   However, as HOCl concentration increased, the protective 
effects of ions became more apparent.  50 µM HOCl with ions has a much lower absorbance than 50 µM 
HOCl without ions; indeed, its absorbance is even lower than 100 µM HOCl without ions.  100 µM 
HOCl with ions also had a lower absorbance than 100 µM HOCl without ions. 
 
 
 
ATP Protects PK-M2 from Oxidation and IAF Tagging 
ATP binds in PK-M2’s active site.  Activity assays performed by Julia show that moderate 
concentrations of ATP exhibit protective effects against oxidation by HOCl.  PK-M2 activity is retained 
at 100 µM HOCl with the addition of 75 µM ATP. 
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Figure 19. Ions Inhibit IAF Tagging: Absorbance Spectra.  IAF reacts with reduced thiols to form a stable 
tag that absorbs at 498 nm.  Oxidation of PK-M2 and the presence of ions reduces the number of accessible 
sulfhydryl residues and inhibits IAF tagging. 
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Figure 20. Effects of Oxidation on PK-M2 Activity (Zuercher, 2017).  PK-M2 activity is measured as a 
decrease in absorbance at 340 nm as NADH is oxidized to NAD+.  Oxidation decreases PK-M2’s activity, 
but ATP (75µM) protects against inactivation by HOCl. 
 
 
 
SDS-PAGE results shown below demonstrate a clear decrease in the extent of IAF tagging as the 
concentration of ATP increases.   Interestingly, 37.5 and 75 µM ATP have about the same extent of IAF 
tagging.  As ATP concentration increases, however, IAF labeling decreases more consistently.  Addition 
of ATP inhibits IAF labeling of cysteines. 
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Figure 21. Effects of ATP on IAF Tagging: Gel.  IAF reacts with reduced thiols to form a stable fluorescent 
tag.  Increasing concentrations of ATP decrease the extent of IAF labeling of PK-M2.   
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Samples of PK-M2 incubated with 75 µM ATP for 10 minutes had a lower absorbance at 498 nm 
than samples of PK-M2 without ATP.   
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Figure 22. Effects of ATP on IAF Tagging: Gel Summary.  Average fluorescent intensity obtained from 
SDS-PAGE was converted to a percent of the control.  Values displayed above represent the average of four 
trials.  Increasing concentrations of ATP decrease the accessibility of cysteines within the protein and 
inhibit IAF tagging. 
 
Figure 23. Effects of ATP on IAF Tagging: Absorbance Spectra.  IAF reacts with reduced thiols to form a 
stable tag that absorbs at 498 nm.  ATP absorbs at 262 nm.  Addition of ATP reduces the accessibility of 
cysteine residues and inhibits IAF tagging. 
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Figure 25. Effects of PEP on PK-M2 Oxidation: Gel Summary.  Average fluorescent intensity obtained 
from SDS-PAGE was converted to a percent of the control.  Values displayed above represent the average 
of three trials.  Oxidation of PK-M2 reduces the number of accessible sulfhydryl residues and inhibits IAF 
tagging.  Addition of PEP elicited no protective effect against oxidation or IAF labeling. 
PEP Has No Effect on PK Oxidation or IAF Tagging	 	 	 	 	 	  
 PEP is a substrate in PK’s glycolytic reaction.  SDS-PAGE analysis shows almost no difference 
between the extent of IAF labeling after oxidation with and without the addition of 75 µM PEP.  
 
 
 
 
 
 
 
 
Absorbance measures show that the differences in the extent of IAF labeling between samples 
with and without PEP are minimal.   
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Figure 24. Effects of PEP on PK-M2 Oxidation: Gel.  IAF reacts with reduced thiols to form a stable 
fluorescent tag.  Oxidation of PK-M2 with HOCl reduces the number of accessible sulfhydryl residues and 
inhibits IAF tagging.  Addition of PEP exerted no effect on cysteine accessibility to HOCl or IAF. 
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Figure 27. Effects of DTNB on PK-M2 Activity (Zuercher, 2017).  PK-M2 activity is measured as a 
decrease in absorbance at 340 nm as NADH is oxidized to NAD+.  Addition of DTNB decreases PK-M2 
activity. 
 
 			
DTNB Inhibits PK-M2 Activity and IAF Tagging 
DTNB is a thiol-specific reagent used to quantify sulfhydryls in proteins because it forms stable 
disulfide linkages with cysteines.  Julia found that 200 µM DTNB inhibits PK-M2 activity.   
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Figure 26. Effects of PEP on IAF Tagging: Absorbance Spectra.  IAF reacts with reduced thiols to form a 
stable tag that absorbs at 498 nm.  Oxidation of PK-M2 reduces the number of accessible sulfhydryl 
residues and inhibits IAF tagging.  Addition of PEP exerted a negligible effect on cysteine accessibility. 
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Figure 29. Effects of DTNB of IAF Tagging: Gel Summary.  Average fluorescent intensity obtained from 
SDS-PAGE was converted to a percent of the control.  Values displayed above represent the average of 
three trials.  Addition of DTNB reduces the number of accessible sulfhydryl residues and inhibits IAF 
tagging.  
DTNB binds to PK-M2’s cysteine residues and precludes IAF labeling.  Indeed, addition of 
DTNB to samples results in about 70% less IAF tagging as determined by SDS-PAGE.  Increasing 
DTNB concentrations result in decreased labeling by IAF.    
 
 
 
 
\ 
 
 
 
 
 
 Absorbance measures show an increased generation of TNB2- with the addition of PK.  TNB2- is 
a yellow product, and Figure 30 below shows the extent of its formation at various concentrations of 
HOCl.  No TNB2- is formed when there are no available thiol groups to react with.  The addition of 
HOCl decreases the number of cysteines available to react with DTNB, which decreases the extent of 
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Figure 28. Effects of PEP on PK-M2 Oxidation: Gel.  IAF reacts with reduced thiols to form a stable 
fluorescent tag.  Addition of DTNB reduces the number of accessible sulfhydryl residues and inhibits IAF 
labeling. 
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TNB2- formation.  TNB2- formation is inversely related to HOCl concentration. 
 
 
FBP Protects PK-M2 from IAF Tagging 
 FBP is an allosteric activator of PK-M2.  Possible protective effects of FBP on IAF labeling 
were assessed using SDS-PAGE.  Increasing FBP concentrations decreased the extent of IAF tagging, 
and this effect increased with time. 
 
 
 
 
Figure 31. Effects of FBP on IAF Tagging: Gel.  IAF reacts with reduced thiols to form a stable fluorescent 
tag.  Increasing concentrations of FBP decrease the extent of IAF labeling of PK-M2.  
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Figure 30. DTNB Reacts with Cysteines and Forms TNB2-.  Control contains only buffer, DTNB, and IAF 
and shows no generation of yellow TNB2- product.  TNB2- formation is visible in slight coloration of samples 
6, 7, and 8 (each contain PK, buffer, DTNB, and IAF).  DTNB reacts with cysteines of PK to form mixed 
disulfides and TNB2-.  Oxidation decreases the number of cysteines available to react with DTNB and 
decreases of TNB2- formation.	
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 			 Absorbance measures at 498 nm show a decrease in IAF tagging as FBP concentration increases.  
This decrease proceeded in a stepwise manner, with 37.5 and 75 µM FBP absorbing with approximately 
the same intensity.  100 and 150 µM FBP are also similar in absorbance intensity at 498 nm.  330 µM 
FBP has the lowest absorbance, indicating that increasing FBP concentrations inhibits PK-M2 IAF 
labeling. 
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Figure 32. Effects of FBP on IAF Tagging: Gel Summary.  Average fluorescent intensity obtained from 
SDS-PAGE was converted to a percent of the control.  Values displayed above represent the average of two 
trials.  An additional 10 minutes of incubation with FBP further decreases the extent of IAF labeling.  
Increasing concentrations of FBP decrease the accessibility of cysteines within the protein and inhibit IAF 
tagging.   
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Figure 33. Effects of FBP on IAF Tagging: Absorbance Spectra.  IAF reacts with reduced thiols to form a 
stable tag that absorbs at 498 nm.  Figure 33.A shows the entire peak at 498 nm.  Figure 33.B is zoomed in 
on the peak’s maximum to show the similar absorption profiles between certain concentrations of FBP.  
Addition of FBP reduces the number of accessible sulfhydryl residues and inhibits IAF tagging.   
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Discussion 
The accessibility of cysteines within 
proteins in ligand-dependent (Oberfelder et 
al.¸1984).  This research concentrated on 
understanding the effects of certain ligands 
and oxidizing environments on the 
accessibility of sulfhydryl residues in PK-
M2.   
Oxidation Inhibits PK-M2 Activity and IAF Tagging 
Oxidation has been shown to affect the PK-M2’s reactivity and function.  Treatment of PK-M2 
with HOCl results in oxidation of cysteine residues and the formation of disulfide bridges.  These 
covalent bonds can induce conformational changes in the protein’s tertiary structure. Cys-357, located 
near the active site, is critical for PK-M2’s enzymatic function.  Anastasiou et al. showed that oxidation 
of this residue results in inactivation of the enzyme (2011).  Because of the importance of Cys-357 in 
catalysis, it is buried in the (β/α)8-barrel of Domain A.  
 
Figure 34. Structure of pyruvate kinase tetramer (PK) with 
cysteines. FBP binding site (blue), active site (red), cysteines 
(green).  Drawn from 1A49.pdb 
Figure 35. Oxidation Inhibits IAF Labeling.  Addition of HOCl causes the formation of disulfide bridges.  IAF 
can only react with reduced thiols, so oxidation decreases the extent of IAF reaction of PK.	
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It is postulated that 100 µM HOCl oxidizes Cys-357, which results in the protein’s inactivation.  
Prior to the 100 µM mark, however, other, more exposed cysteines are oxidized.  Indeed, at 50 µM, the 
extent of IAF labeling is already only 32% of theoretical A498.  The theoretical absorbance of IAF-
labeled PK is a function of the concentration of cysteines in the system and the molar extinction 
coefficient (ɛ) of IAF (80,000-85,000 M-1cm-1).	 !!!!"#!$%&'( = [!"#]×ɛ!"# 
If all cysteines were tagged, PK-M2 would have an absorbance of 1.68.  However, many 
cysteines in PK-M2 are 
buried within the 
tetrameric structure and 
are thus unlikely to be 
tagged by IAF without 
the addition of a 
detergent.  Indeed, the 
maximum recorded 
absorbance for PK-M2 is 
0.827, representing 49% 
of all cysteines being 
tagged.  Likely candidates for oxidation or IAF labeling are shown in Figure 37.  These cysteines are 
located near the enzyme’s interface with the solvent and are thus more reactive.  Sixteen of 36 total 
cysteines per PK-M2 tetramer have been identified as particularly susceptible to reaction.  
 IAF can only react with reduced thiols; PK-M2 oxidation, with its formation of disulfide 
bridges, inhibits IAF tagging.  Increasing concentrations of oxidant in the reaction mixture decrease the 
Figure 36. Oxidation Inhibits IAF Tagging: Theoretical Comparison.  IAF reacts with 
reduced thiols to form a stable tag that absorbs at 498 nm.  Oxidation decreases realized 
absorbance to 49%, 32%, and 20% of theoretical A498 for 0, 50, and 100 µM HOCl 
respectively.  Oxidation of PK reduces the accessibility of cysteine residues and inhibits 
IAF tagging.   
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extent of IAF labeling of PK-M2 through a reduction in the number of reduced thiols available for 
tagging.  Addition of 50 and 100 µM HOCl decreases the recorded A498 to 32% and 20% of theoretical 
A498 respectively.  
	 Oxidation with HOCl decreases PK-M2 activity by oxidizing a critical residue, Cys-357.  Low 
concentrations of HOCl do not affect PK-M2 activity because this cysteine is buried in the active site.  
Low concentrations of HOCl do affect IAF tagging because oxidation promotes the formation of 
disulfide bridges which inhibit IAF tagging ability.  As the concentration of HOCl increases, the extent 
of IAF labeling decreases because more cysteines are oxidized and become inaccessible.  HOCl 
oxidation inhibits PK-M2 activity and IAF labeling via the formation of disulfide bonds.  
 
 
 
 
 
 
 
 
Ions Protect PK-M2 from IAF Tagging 
The addition of ions affected IAF tagging.  This inhibition may have resulted from an altered 
SDS-binding profile in SDS-PAGE, varied labeling affinities for IAF, or protective effects of ions 
against HOCl oxidation.  Further research is necessary to investigate this relationship.  
Figure 37.  Binding sites for PK with vulnerable cysteines.  Comparison with theoretical 
absorbance reveals that only about half of all cysteines are tagged.  Above, the 16 most 
exposed of 36 total cysteines are shown in yellow.  Buried cysteines (green), active site (red), 
FBP binding site (blue). Enzyme is rotated 90°. Drawn from 1A49.pdb. 
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Ions decreased the recorded absorbance at 498 nm across oxidative environments.  The 
absorbance at 0 µM HOCl was quite similar between samples with and without ions.  At 50 µM HOCl, 
ions decreased the recorded absorbance from 32% (without ions) to 17% (with ions) of theoretical A498.  
At 100 µM HOCl, ions decreased the recorded absorbance from 19% (without ions) to 11% (with ions) 
of theoretical A498.  Addition of 100 mM KCl and 10 mM MgSO4 to the reaction caused significant 
changes to the extent of IAF labeling in PK-M2.   
 
 
 
 
ATP Protects PK-M2 from Oxidation and IAF Tagging 
Addition of 75 µM ATPwas shown to protect PK-M2 activity against oxidation by HOCl.  At 
low concentrations, ATP likely blocks access to Cys-357, a critical residue located near the enzyme’s 
active site.  ATP binds near this residue and blocks both HOCl and IAF from accessing this cysteine.  
Low concentrations of ATP block access to a few cysteines.  At moderate ATP concentrations, this 
ligand still only inhibits IAF tagging of specific residues, shown as a flattening of the curve in Figure 22.  
However, when ATP concentrations exceed 150µM, ATP binds less specifically.  These high 
0% 
10% 
20% 
30% 
40% 
50% 
60% 
0 µM 50 µM 100 µM 
%
 T
he
or
et
ic
al
 A
bs
 a
t 4
98
 n
m
 
[HOCl] 
Figure 38. Ions Inhibit IAF Tagging: Theoretical Comparison.  IAF reacts with reduced thiols to form a 
stable tag that absorbs at 498 nm.  Oxidation decreases realized absorbance to 49%, 32%, and 20% of 
theoretical A498 for 0, 50, and 100 µM HOCl respectively.  Addition of ions results further diminishes the 
realized absorbances to 47%, 17%, and 11% of theoretical A498. Addition of ions affects the extent of 
IAF labeling. 
42	
concentrations result in less specific blocking of cysteines; other cysteines located near the active site 
include Cys-48, Cys-316, and Cys-325.  
 
 
Absorbance measures show than instead of 47 % of theoretical A498, the addition of 75	µM ATP 
results in 35% tagging of 
cysteines.  This supports 
the idea that critical 
cysteines (four per tetramer 
or 11%) are blocked by 
ATP.  Increasing 
concentrations of ATP in 
the reaction mixture 0% 
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Figure 39. Active site of PK.  Domain B has been removed, so the viewer is looking down the (β/α)8-barrel of Domain 
A.  ATP binds in the active site and specifically blocks access to Cys-357 at 75 µM.  As ATP concentration increases, 
the ligand blocks less specifically.  Cysteines (green), ions (red), key residues (yellow and blue), pyruvate (magenta).  
Drawn from 1PKN.pdb 	
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decrease the extent of IAF labeling of PK-M2 by blocking access to cysteines near ATP’s binding site.  
Each monomer of PK has an active site with Cys-357; this residue is selectively blocked by 
moderate concentrations of ATP as the ligand binds in the active site.  This selective binding results in 
the protective effects of ATP.  Indeed, binding of ATP blocks access to Cys-357, which prevents 
oxidation and IAF labeling of this critical residue.	 
PEP Has No Effect on PK-M2 Oxidation or IAF Tagging 
At 2 mM, PEP has been shown to make sulfhydryl groups less accessible by increasing the 
compactness of PK (Oberfelder et al., 1984; Ou et al., 2010).  At 75 µM, PEP does not affect the extent 
of IAF labeling of PK-
M2.  Though PEP does 
bind in the protein’s 
active site like ATP, it did 
not exert any protective 
effects against IAF or 
HOCl accessing Cys-357 or 
other cysteines near the 
(β/α)8-barrel.  Further 
research could be 
undertaken to investigate at 
what concentration PEP 
begins to affect PK-M2 
conformation.   
Figure 41. Effects of PEP on IAF Tagging: Theoretical Comparison.  IAF reacts with 
reduced thiols to form a stable tag that absorbs at 498 nm.  Oxidation decreases realized 
absorbance to 37%, 20%, and 7% of theoretical A498 for 0, 50, and 100 µM HOCl 
respectively.  Addition of PEP decreases the realized absorbances to 35%, 16%, and 
7% of theoretical A498. Addition of 75 µM PEP has no appreciable effect on the extent 
of IAF labeling at 0 and 100 µM HOCl and has a small diminishing effect at 50 µM 
HOCl. 
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Figure 40. Effects of ATP on IAF Tagging: Theoretical Comparison.  IAF reacts with 
reduced thiols to form a stable tag that absorbs at 498 nm.  Without ATP, A498 nm is 
about 47% of theoretical A498.  With ATP, A498 nm is about 35% theoretical A498.  
Addition of ATP reduces the accessibility of cysteine residues and inhibits IAF tagging.   
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Comparison to the theoretical absorbance at 498 nm yields similar results.  At 0 µM HOCl, both 
samples have about 35% of theoretical A498, representing IAF tags on about 13 cysteines per PK 
tetramer.  At 50 µM HOCl, samples without PEP have 20% theoretical A498, whereas samples with PEP 
have 16% theoretical A498.  This difference may be due to one additional cysteine tag on samples 
without PEP.  At 100 µM HOCl, both samples have about 7% of cysteines tagged with IAF.  In sum, 75 
µM PEP does not exert substantial protective effects against oxidation or IAF labeling.   
DTNB Inhibits PK-M2 Activity and IAF Tagging 
DTNB inhibits both PK-M2 activity and IAF tagging.  DTNB reacts with cysteines, so at 200 
µM DTMB, the substrate likely reacts with Cys-357 in PK's active site. The creation of a mixed 
disulfide at this residue inactivates the protein. 
DTNB was used in 10x excess to assess its effects on IAF labeling. DTNB inhibited IAF tagging 
because it also reacts with reduced thiols. Reaction with DTNB occurred first and replaced many 
accessible reduced cysteines with mixed disulfides with the concurrent generation of TNB2-. TNB2-
formation was verified using absorbance measurements at 412 nm and by visual comparison.  Samples 
without PK remained clear, whereas samples with PK turned yellow.  The addition of PK provided a 
thiol for the mixed 
disulfide reaction, which 
results in the formation 
of TNB2-. 
DTNB was used 
to ensure that IAF was 
tagging cysteines within 
Figure 42. DTNB Inhibits IAF Labeling.  DTNB reacts with cysteines (as thiolate anions) 
to form a mixed disulfide and TNB2-.   TNB2- absorbs at 412 nm and its formation causes 
the solution to turn yellow.  IAF is unable to tag the mixed disulfides, so there is no 
absorbance at 498 nm.	
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PK. Since DTNB greatly inhibited IAF tagging, we can conclude that IAF also targets PK's cysteine 
residues. 
FBP Protects PK-M2 from IAF Tagging 
FBP is a potent modulator of PK-M2 activity. Binding of FBP favors the active, tetrameric form 
of PK.  The FBP binding 
site is removed from the 
active site, but it is 
located near Cys-422 
(Cys-418 in S. 
cerevisiae).  Increasing 
concentrations of FBP 
resulted in decreased IAF 
tagging.   
Interestingly, this 
decrease proceeded in a stepwise manner.  The maximum absorbance recorded for this system was 37% 
theoretical A498.  Both 37.5 and 75 µM FBP resulted in about 35% of theoretical A498.  The difference 
between these two A498 is about 2%, which corresponds to a tag on one cysteine residue.  An additional 
cysteine is blocked between 100-150 µM FBP, and another cysteine is blocked at 330 µM FBP.   FBP 
binding limits the extent of IAF tagging.   
Figure 43. FBP Binding Protects Cysteines. Cys-422 in rabbit muscle (above Cys-418 in 
S. cerevisiae) is thought to be protected by FBP binding.  Cysteines (green), FBP 
(magenta), coordinated residues (blue).  Drawn from 1A3W.pdb. 
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Figure 44. Effects of FBP on IAF 
Tagging: Theoretical Comparison.  
IAF reacts with reduced thiols to 
form a stable tag that absorbs at 498 
nm.  Without FBP, A498 nm is about 
37% of theoretical A498.  With low 
concentrations of FBP, A498 nm is 
about 35% theoretical A498.  
Moderate concentrations of FBP 
result in 34% theoretical A498.  High 
concentrations of FBP result in 32% 
of theoretical A498.  Addition of FBP 
reduces the accessibility of cysteine 
residues and inhibits IAF tagging.   
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Conclusion 
 The purpose of this research is to understand the cysteine modifications of PK under 
physiologically relevant conditions.  Cysteines are unique residues with myriad functional properties.  
However, the chemistry that makes cysteines versatile agents in biochemical processes also makes them 
vulnerable to oxidation.  Within proteins, cysteines can be modified by oxidation and blocked by 
allosteric regulators.   
Oxidation of cysteines can be reversible.   A sulfenic acid can form a disulfide bond with a 
proximal thiol group, which can then be reduced to the two initial sulfhydryls by redox proteins.  
However, the absence of nearby reduced thiols can result in irreversible oxidation.   Both reversible and 
irreversible oxidation alters protein cysteines. 
Allosteric effectors can also modify cysteines.  Binding of these ligands can induce 
conformational changes.  For example, PEP has been shown to decrease the accessibility of sulfhydryls 
in PK by affecting the protein’s global conformation (Oberfelder et al., 1984).   In addition to inducing 
structural changes, allosteric regulators may bind to the enzyme in a location that blocks other species 
from interacting with cysteines.  We postulate that ATP’s binding in the active site precludes IAF 
tagging or HOCl oxidation of Cys-357.  The allosteric regulator—in this case ATP—creates a barrier 
that protects a critical cysteine.  Allosteric effectors modify cysteine accessibility by perturbing protein 
structure and creating physical shields through their binding.   
Our research only touched on the possibilities of the study of cysteine reactivity in glycolytic 
enzymes.  In the future, researchers could investigate the roles of other small molecule allosteric 
effectors such as alanine, phenylalanine, or serine.   These downstream metabolites affect PK activity 
and bind in a location disparate from PEP/ADP and FBP binding sites.  Additionally, it could be 
interesting to investigate the synergistic effects of allosteric regulators.  Oberfelder et al. showed that the 
48	
presence of FBP and ions leads to larger conformational changes upon PEP binding in the active site 
(1984).  Our research did not show that PEP affected IAF labeling at 75 µM; however, the addition of 
FBP or ions to the system may cause PEP to exert protective effects on cysteines.  Serine and FBP create 
synergies for PK activity, but it is unknown what effects these pairings have on cysteine reactivity. 
Many questions remain to be explored in furthering our understanding of the effects of allosteric 
regulators on PK and other glycolytic proteins.   
Studying cysteine modifications allows us to further our understanding of ROS.  Oxidative stress 
is implicated in many pathologies, from cancer to Alzheimer’s.  Cysteine reactivity may be critical to 
unraveling the consequences of oxidative stress on key proteins like glycolytic enzymes.  Furthering our 
understanding of the effects of ROS on specific proteins could have significant implications in the study, 
diagnosis, and treatment of ROS-mediated diseases. 		  
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Appendix 
Chemical Index 
Compound  Abbreviation Structure 
5-(Iodoacetamido)fluorescein IAF 
 
5,5′-Dithiobis(2-nitrobenzoic 
acid) 
DTNB 
 
Cysteine Cys 
 
Fructose-1,6-bisphosphate FBP 
 
Glutathione GSH 
 
Phosphoenolpyruvate PEP 
 
Pyruvate  
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Abbreviation Compound 
EGF Epidermal growth factor 
Gpx Glutathione peroxidases 
NADH Nicotinamide adenine dinucleotide 
NADPH Nicotinamide adenine dinucleotide phosphate 
PK Pyruvate kinase 
Prx Peroxiredoxins 
ROS Reactive oxygen species 
SOD Superoxide dismutases 
Trx Thioredoxins 
 	
Standard Mixtures for Gel Electrophoresis 
For two 1.5 mm separating gels  
 
 7.5% 
Water 10.0 mL 
1.5M Tris pH 8.8 5.0 mL 
30% acrylamide 5.0 mL 
10% SDS 200 µL 
Ammonium persulfate 100 µL 
TEMED 10 µL 
 
For two 1.5 mm stacking gels (4%)  
 
 7.5% 
Water 3.05 mL 
0.5M Tris pH 6.8 1.25 mL 
30% acrylamide 0.67 mL 
10% SDS 50 µL 
Ammonium persulfate 50 µL 
TEMED 5 µL 
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